MENU
XBI
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

SPDR® S&P Biotech ETF (XBI) Ownership - Who owns SPDR® S&P Biotech ETF?

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U... Show more

Category: #Health

Profile

Category
Health
Address
SPDR Series TrustOne Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com

Details

Group
Domestic Stock Funds
Category
Health
Net Assets
5383094300.00
Fund Existence
about 19 years
Turnover
90.00
Capitalization
N/A
Yield
0.15
Total Expense Ratio
0.35
Investment Style
N/A
Risk (Beta)
0.96

Fundamentals

XBI
Net Assets
5.38B
Yield
0.15
Fund Existence
about 19 years
Total Expense Ratio
0.35
Turnover
90.00
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
0.96
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
0.35
Assets in Top Ten Holdings
832M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
5.38B
Fund Type
ETF
Index Fund
Yes
Management Fee
0.35
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
142.00
Number of Net Holdings
142.00
Number of Short Holdings
N/A
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
26.42%
Gain YTD
-6.279
View a ticker or compare two or three
XBI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
SPDR Series TrustOne Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com